DCIS treated with excision alone using the national comprehensive cancer network (NCCN) guidelines

Annals of Surgical Oncology

Volumn 20, Issue 10, 2013, Pages 3175-3179

  Wehner, Patricia ^a   Lagios, Michael D ^b   Silverstein, Melvin J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Breast Cancer Consultation Service Location   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; DATA BASE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RECURRENCE RISK; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84883829724     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3176-2     Document Type: Article

References (27)

1. Lagios M, Page D, Silverstein M. Prospective study of wide excision alone for ductal carcinoma in situ of the breast [comment]. J Clin Oncol. 2006;24:3809-11.
2. Lagios MD. Duct carcinoma in situ: pathology and treatment. Surg Clin N Am. 1990;70:853-71.
3. Schwartz G. The role of excision and surveillance alone in subclinical DCIS of the breast. Oncology. 1994;8(2):21-6.
4. Schwartz G, Finkel G, Carcia J, Patchefsky A. Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone. Cancer. 1992;70:2468-74.
5. Silverstein MJ, Lagios M, Groshen S, et al. The influence of margin width on local control in patients with ductal carcinoma in situ (DCIS) of the breast. New Engl J Med. 1999;340:1455-61.
6. Silverstein MJ, Poller D, Craig P, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267-74.
7. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328:1581-6.
8. Silverstein MJ. The University of Southern California / Van Nuys Prognostic Index for ductal carcinoma in situ of the breast. Am J Surg. 2003;186:337-43.
9. Silverstein MJ, Lagios M, Recht A, eds. Ductal carcinoma in situ of the breast, 2nd edn. Philadelphia: Lippincott Williams & Wilkins; 2002.
10. Carlson RW, Allred DC, Anderson BO, et al. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. 2008; www.nccn.org, 2008.
11. Therialt RT, Carlson RW, Allred C, et al. NCCN Guidelines Breast Version 2.2013. Breast Cancer. 2013; www.NCCN.org.
12. Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med. 2009;133(1):15-25.
13. Fisher B, Redmond C, ER F. Radiation therapy for in situ or localized breast cancer: the authors reply. N Engl J Med. 1993;329:1578.
14. Fisher E, Dignam J, Tan-Chie E, et al. Pathologic findings from the National Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer. 1999;86:429-38.
15. Wapnir I, Dignam J, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478-88.
16. Viani GA, Stefano EJ, Afonso SL, et al. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiation Oncol. 2007;2:28-39.
17. (EBCTCG) EBCTCG. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Monogr. 2010;41:162-77.
18. Lagios M, Margolin F, Westdahl P, Rose N. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 1989;63:619-24.
19. Lagios M, Westdahl P, Margolin F, Rose M. Duct Carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer. 1982;50:1309-14.
20. Schwartz G, Patchefsky A, Finkelstein S, et al. Nonpalpable in situ ductal carcinoma of the breast. Arch Surg. 1989;124:29-32.
21. Silverstein MJ. An argument against routine use of radiotherapy for ductal carcinoma in situ. Oncology. 2003;17(11):1511-46.
22. Lagios M. Controversies in diagnosis, biology, and treatment. Breast J. 1995;1:68-78.
23. Lagios M. The Lagios experience. In: Silverstein MJ, Recht A, Lagios M, eds. Ductal carcinoma in situ of the breast, 2nd edn. Philadelphia: Lippincott Williams & Wilkins; 2002:303-7.
24. Silverstein MJ, Epstein M, Sposto R. Predicting local recurrence in patients with DCIS. In: Silverstein MJ, Recht A, Lagios M, eds. Ductal carcinoma in situ of the breast, 2nd edn. Philadelphia: Lippincott Williams & Wilkins; 2002.
25. Hughes L, Molin W, Page D, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27(32):5319-24.
26. Darby S, McGale P, Taylor C, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women un US SEER cancer registries. Lancet Oncol. 2005;6:557-65.
27. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987-98.